Results 201 to 210 of about 155,160 (352)

MEMBRANOUS INTESTINAL DIGESTION CHARACTERISTICS IN PATIENTS WITH CHRONIC PANCREATITIS

, 2009
О.А. Stгокоva, Е. Ю. Еремина   +1 more
openalex   +1 more source

S07 * COMBINED DEPENDENCE FROM ALCOHOL AND TOBACCO: INTERACTIONS AND CLINICAL IMPLICATIONS * S07.1 * THE IMPACT OF SMOKING AND ALCOHOL ON ACUTE AND CHRONIC PANCREATITIS IN THE WESTERN WORLD [PDF]

, 2011
R. Pfützer, Norbert Wodarz, Fredrick Weber, A. Grundl, S. Appel, Monika Ridinger, Sebastian Müller, Sylvie Petitjean, Bigna Degen, Gerhard A. Wiesbeck, Stephan Haas   +10 more
openalex   +1 more source

Identification of Common Blood Metabolic Derangements Using Magnetic Resonance Signatures of the Pancreas and Liver

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim To investigate whether common disturbances of glucose and lipid metabolism can be automatically identified from magnetic resonance signatures of the pancreas and liver. Methods In this proof‐of‐principle study, 100 individuals with a history of pancreatitis—a relatively homogeneous population at risk for metabolic derangements—underwent ...
Wandia Kimita, Juyeon Ko, Loren Skudder‐Hill, Xiatiguli Shamaitijiang, Yutong Liu, Maxim S. Petrov   +5 more
wiley   +1 more source

Quality of life in children with chronic pancreatitis: An overlooked challenge. [PDF]

World J Clin Pediatr
Agrawal A, Samanta A.
europepmc   +1 more source

GLP‐1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background The escalating use of Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) is reshaping pharmaceutical consumption patterns and posing unprecedented challenges to healthcare systems worldwide. This study analyzes the landscape of GLP‐1 RA consumption, safety monitoring and regulatory oversight in Brazil.
Renato Lopes Hurtado, Angélica Amorim Amato, Hugo de Luca Corrêa, Dâmaris Silveira   +3 more
wiley   +1 more source

Hybrid surgical approach for chronic pancreatitis: pyloric-ring-resection pancreaticoduodenectomy with lateral pancreatojejunostomy. [PDF]

J Surg Case Rep
Barakat O, Mortus JR, Ozaki CF.
europepmc   +1 more source

Cardio‐Kidney‐Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Kidney and cardiovascular diseases are highly prevalent among patients with Type 1 diabetes. To date, no randomised clinical trial has reported on the impact of novel cardio‐kidney‐metabolic (CKM) therapies (GLP‐1RA and SGLT2i) on kidney function in this population.
M. Luiza Caramori, Enrico Repetto, Christopher Perkins, Ambarish Pandey, Peter Rossing   +4 more
wiley   +1 more source

Prostaglandin E2 as a Mechanistic Biomarker of Chronic Pancreatitis. [PDF]

Clin Transl Gastroenterol
Saloman JL, Jefferson B, Han S, Fisher WE, Fogel EL, Hart PA, Li L, Park WG, Vege SS, Yadav D, Topazian MD, Conwell DL, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).   +14 more
europepmc   +1 more source

Splenic artery aneurysms occurring in liver transplant recipients [PDF]

, 1991
Bronsther, O, Merhav, H, Starzl, TE, Van Thiel, D   +3 more
core   +1 more source

Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the association between semaglutide 2.4 mg and major adverse cardiovascular events (MACE) among adults with clinical atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity without diabetes in real‐world clinical practice.
Michael G. Nanna, Carlos Mena‐Hurtado, Victoria Divino, Zhenxiang Zhao, Yan Chen, Joanna Boland, Jinlin Song, Andrea Traina, Kerem Ozer, Filip K. Knop, Kim G. Smolderen   +10 more
wiley   +1 more source